Amgen Inc (AMGN)
Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell
$281.50
Buy
$285.55
$4.64 (+1.64%)
Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.
Prices updated at 31 May 2025, 00:59 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
| Year | Gross margin (%) | Operating margin (%) | Net margin (%) | EBITDA margin (%) | EBITDA |
|---|---|---|---|---|---|
| 2024 | 61.53 | 21.71 | 12.24 | 39.96 | 13,356m |
| 2023 | 70.02 | 28.01 | 23.83 | 52.50 | 14,801m |
| 2022 | 75.66 | 36.34 | 24.89 | 46.23 | 12,169m |
| 2021 | 75.16 | 35.20 | 22.68 | 43.48 | 11,296m |
| 2020 | 75.77 | 35.95 | 28.57 | 51.12 | 12,996m |
| 2019 | 81.35 | 41.41 | 33.57 | 54.08 | 12,633m |
| 2018 | 82.73 | 43.22 | 35.35 | 54.25 | 12,883m |
| 2017 | 82.19 | 43.65 | 8.66 | 56.27 | 12,856m |
| 2016 | 81.90 | 42.60 | 33.59 | 54.49 | 12,528m |
Valuation data table
| Year | Price / Sales | Price earnings | Price / Cash flow |
|---|---|---|---|
| 2025 | 4.58 | 26.27 | 12.82 |
| 2024 | 4.33 | 33.29 | 19.40 |
| 2023 | 5.77 | 20.49 | 14.64 |
| 2022 | 5.46 | 21.08 | 14.55 |
| 2021 | 5.05 | 23.19 | 15.11 |
| 2020 | 5.46 | 18.53 | 12.56 |
| 2019 | 6.39 | 18.52 | 15.20 |
| 2018 | 5.73 | 50.70 | 12.02 |
| 2017 | 5.58 | 15.71 | 11.41 |
| 2016 | 4.92 | 14.64 | 12.80 |
| 2015 | 5.81 | 19.37 | 13.18 |
Price/Forward earnings (YTD)
13.81
Returns
Debt profile
Returns data table
| Year | Return on assets (%) | Return on equity (%) | Return on invested capital (%) |
|---|---|---|---|
| 2024 | 4.33 | 67.55 | 10.07 |
| 2023 | 8.28 | 135.79 | 16.17 |
| 2022 | 10.38 | 126.47 | 18.90 |
| 2021 | 9.50 | 73.16 | 16.86 |
| 2020 | 11.84 | 76.13 | 20.47 |
| 2019 | 12.44 | 70.73 | 20.81 |
| 2018 | 11.47 | 44.48 | 16.87 |
| 2017 | 2.51 | 7.18 | 3.53 |
| 2016 | 10.36 | 26.65 | 13.31 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 15.63 |
| 2023 | 15.59 |
| 2022 | 17.79 |
| 2021 | 9.13 |
| 2020 | 6.69 |
| 2019 | 6.17 |
| 2018 | 5.31 |
| 2017 | 3.17 |
| 2016 | 2.60 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
